Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenerative Medical Technology (RMTG) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for Regenerative Medical Technology (RMTG) over the last 7 years, with Q3 2025 value amounting to 1.12.

  • Regenerative Medical Technology's Asset Utilization Ratio rose 935.53% to 1.12 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.12, marking a year-over-year increase of 935.53%. This contributed to the annual value of 1.23 for FY2024, which is 17876.93% up from last year.
  • According to the latest figures from Q3 2025, Regenerative Medical Technology's Asset Utilization Ratio is 1.12, which was up 935.53% from 1.14 recorded in Q2 2025.
  • In the past 5 years, Regenerative Medical Technology's Asset Utilization Ratio registered a high of 1.19 during Q1 2025, and its lowest value of 0.01 during Q2 2021.
  • For the 5-year period, Regenerative Medical Technology's Asset Utilization Ratio averaged around 0.52, with its median value being 0.27 (2023).
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first plummeted by 9954.66% in 2021, then soared by 187656.29% in 2022.
  • Regenerative Medical Technology's Asset Utilization Ratio (Quarter) stood at 0.03 in 2021, then skyrocketed by 464.94% to 0.19 in 2022, then surged by 314.77% to 0.78 in 2023, then surged by 49.75% to 1.17 in 2024, then decreased by 3.97% to 1.12 in 2025.
  • Its Asset Utilization Ratio stands at 1.12 for Q3 2025, versus 1.14 for Q2 2025 and 1.19 for Q1 2025.